10.6-μm infrared laser as adjuvant therapy for diabetic peripheral neuropathy: study protocol for a double-blind, randomized controlled trial
Abstract Background Diabetic peripheral neuropathy (DPN) is the most common chronic neurological complication. It is the main cause of disability in diabetes mellitus (DM) patients and seriously affects the quality of life of patients. Pharmacological treatments always associate with limited efficac...
Main Authors: | Lin Lin, Yi Chen, Yuxia Li, Ke Cheng, Haiping Deng, Jianping Lu, Ling Zhao, Xueyong Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05901-6 |
Similar Items
-
Effect of 10.6 μm laser moxibustion on inflammation in diabetic peripheral neuropathy rats
by: Yue Yin, et al.
Published: (2023-08-01) -
Effect of mild moxibustion in improving the quality of life of patients with diabetic peripheral neuropathy
by: Dou-Dou Li, et al.
Published: (2020-01-01) -
Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy
by: Wu Y, et al.
Published: (2022-11-01) -
Focal Peripheral Neuropathies (4th ed)
by: Colin Chalk
Published: (2010-10-01) -
Peripheral neuropathy and the role of nerve biopsy: A revisit
by: Ishita Pant, et al.
Published: (2018-01-01)